CASTLEARK MANAGEMENT LLC LGND LIGAND PHARMACEUTICALS INC

Ownership history in CASTLEARK MANAGEMENT LLC  ·  33 quarters on record

AI Ownership Summary

CASTLEARK MANAGEMENT LLC reported LIGAND PHARMACEUTICALS INC (LGND) in 33 quarterly 13F filings from 2024 Q1 through 2026 Q2. Peak portfolio weight reached 0.53% in 2026 Q2. The latest visible filing shows LGND at 0.53% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings. Older history is available after unlock; the visible window still shows the most recent pattern.

What this LGND ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was CASTLEARK MANAGEMENT LLC's position in LIGAND PHARMACEUTICALS INC, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2026 Q2

LGND was reported at 0.53% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
0.53% in 2026 Q2

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2024 Q1 to 2026 Q2

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

How CASTLEARK MANAGEMENT LLC held LGND — position size vs. price
% of Fund (quarterly)    LGND price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
📋 Quarterly Holdings History 9 quarters  
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2026 Q2 ADDED 62,043 +13,347 +27.4% 0.53% $19.6M 2026-08-14 $294.60
2026 Q1 REDUCED 27.0% +57.3% 48,696 -18,040 -27.0% 0.32% $9.7M 2026-05-15 $213.21
2025 Q4 ADDED 66,736 +2,060 +3.2% 0.37% $12.6M 2026-02-13 $183.83
2025 Q3 REDUCED 64,676 -1,787 -2.7% 0.32% $11.5M 2025-11-17 $201.35
2025 Q1 ADDED 66,463 +1,350 +2.1% 0.24% $7.0M 2025-05-15 $103.47
2024 Q4 REDUCED 65,113 -2,810 -4.1% 0.24% $7.0M 2025-02-18 $119.99
2024 Q3 ADDED 67,923 +6,560 +10.7% 0.28% $6.8M 2024-11-15 $111.71
2024 Q2 REDUCED 61,363 -550 -0.9% 0.21% $5.2M 2024-08-14 $101.02
2024 Q1 REDUCED 61,913 -789 -1.3% 0.19% $4.5M 2024-05-16 $85.02
24 older quarters hidden  —  Sign in free or upgrade to Premium to see full history

FAQ About CASTLEARK MANAGEMENT LLC and LGND

These are the practical questions this page is built to answer before you even open the full history table.

How long has CASTLEARK MANAGEMENT LLC reported owning LGND?

CASTLEARK MANAGEMENT LLC reported LGND across 9 quarterly 13F filings, from 2024 Q1 through 2026 Q2.

What was the largest reported LGND position in CASTLEARK MANAGEMENT LLC's portfolio?

The largest reported portfolio weight for LGND was 0.53% in 2026 Q2.

What is the latest reported LGND position on this page?

The most recent filing on this page is 2026 Q2, when CASTLEARK MANAGEMENT LLC reported 62,043 shares, equal to 0.53% of portfolio, with an estimated market value of $19.6M.

What does the chart on this LGND ownership page compare?

The chart compares CASTLEARK MANAGEMENT LLC's quarterly LGND portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

How well did CASTLEARK MANAGEMENT LLC time their LGND position?

Based on 13F filing dates vs. subsequent LGND price moves, CASTLEARK MANAGEMENT LLC correctly timed 17 out of 32 reported position changes (53%). The annualised alpha on LGND relative to SPY over the holding period was +37.1%.

← Back to CASTLEARK MANAGEMENT LLC Holdings